Hadly Clark is an associate director on the FasterCures team at Milken Institute Health. She is an experienced health care professional focused on the intersection of health and technology and leads oncology-focused initiatives exploring innovative screening technologies and anti-cancer treatments.
The rapid advancement of the health technology landscape relies heavily on patient data. Patient data from medical records and digital health apps can be leveraged to build new tools that can help diagnose disease, remotely monitor and track patients, and make groundbreaking discoveries that lead to new treatments and cures. Data-reliant entities, such as technology companies, have the most advanced capabilities to aggregate and analyze these data. But, because their activities fall outside of the traditional authority that governs health data privacy, their participation carries substantial implications for how patient data are collected and used.
The Pew Research Center, which publishes an annual survey to measure social trust, defines trust as a “belief in the honesty, integrity, and reliability of others—a ‘faith in people.’" The 2022 annual Edelman Trust Barometer found that distrust is the default for the majority of people. Fifty-nine percent of respondents indicate they tend to distrust until they see evidence that something is trustworthy versus a tendency to trust until they see evidence that something is untrustworthy. According to a poll of 2,200 adults across the country, fewer than three in five Americans trust the US health-care system. Further trust in the scientific, community has eroded since this tracking began in November 2020.
To move toward a system that patients trust, we must paint a clear picture of the desired system. In late 2020, FasterCures brought together experts who work with patient data in various settings to outline key elements of a trusted system. Part of the work was to envision the aspects needed to establish trust. Experts identified three foundational components of trust. For this report, we focus on one of the elements: the need to create strong and clear protections for patient data. The other two elements—ensuring that patients reap benefits from contributing their data and creating safe platforms and spaces for peer groups— are also crucial and will be addressed in our ongoing work.
Even before the onset of the COVID-19 pandemic, the United States was confronted with a number of significant policy concerns. Today, working together to solve those challenges is more imperative than ever. The Milken Institute is committed...
Countries undergoing population aging today are facing a much different experience than their historical counterparts. One only needs to look at the countries in Asia to see how these trends are unfolding. Demographic aging is happening...
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have released a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis. Applications are open through January 20...
The 26th annual Milken Institute Global Conference convened the best minds in the world to tackle its most urgent challenges and realize its most exciting opportunities. Throughout the four-day event, our health teams curated nearly three...
Technical Update Dementia presents a pernicious gender-based health disparity in the United States, inflicting a disproportionate burden on women as both patients and caregivers. Given the rapid increase in the population of older Americans...
Nationwide protests in the summer of 2020 sparked many of the largest US corporations to pledge more than $200 billion to advance racial equity and confront the nation’s history of systemic racism. Nonprofits, government agencies, and...
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) is now accepting applications for two-year research projects that seek to increase our foundational understanding of sarcoidosis through projects focused on the...
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...